Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1-Reference-Cited by-同舟云学术

Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1

Published:2020-11 Issue:8 Volume:1 Page:100141
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Poran Asaf^ORCID,Scherer Julian,Bushway Meghan E.,Besada Rana,Balogh Kristen N.,Wanamaker Amy,Williams Reid G.,Prabhakara Jasmina,Ott Patrick A.,Hu-Lieskovan Siwen,Khondker Zakaria S.,Gaynor Richard B.,Rooney Michael S.,Srinivasan Lakshmi

Funder

Neon Therapeutics/BioNTech US

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference44 articles.

1. II. Contribution to the Knowledge of Sarcoma;Coley;Ann. Surg.,1891

2. Über den jetzigen Stand der Chemotherapie;Ehrlich;Ber. Dtsch. Chem. Ges.,1909

3. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer;Finn;Ann. Oncol.,2012

4. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting;Matsushita;Nature,2012

5. Neoantigens in cancer immunotherapy;Schumacher;Science,2015

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transformers meets neoantigen detection: a systematic literature review;Journal of Integrative Bioinformatics;2024-06-01

2. HIV infection and ART exposure affect tumor TCR repertoire of diffuse large B cell lymphoma;JCI Insight;2024-05-23

3. Single-cell immune repertoire analysis;Nature Methods;2024-04-18

4. Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy;Clinical Cancer Research;2024-04-17

5. Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?;Pharmacology & Therapeutics;2024-04